Home / Import refusals / SCS-3261758-4/11/2

FDA Import Refusal SCS-3261758-4/11/2 — Rxhomeo Private Limited

Rxhomeo Private Limited — FEI 3005269310

The FDA refused shipment SCS-3261758-4/11/2 from Rxhomeo Private Limited (India) on September 6, 2022. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 27 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 6, 2022
Country
India
Product Category
Drugs and Biologics
Product Code
66VDA99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
27

Recent inspections

  • 1209017 (OAI Fri May 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • SCS-6574310-9/11/1 (Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-5459895-1/11/1 (Thu Jan 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-5461093-9/11/1 (Thu Jan 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-5533611-2/11/1 (Thu Jan 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Human Foods)
  • SCS-3137503-6/11/1 (Wed Sep 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources